MarketPulse

manufacturing defects

4 articles
GlobeNewswire Inc.GlobeNewswire Inc.··The Schall Law Firm

Atara Biotherapeutics Faces Securities Fraud Lawsuit Over Concealed Manufacturing, Clinical Trial Issues

Schall Law Firm launches securities fraud lawsuit against Atara Biotherapeutics for allegedly misrepresenting manufacturing capabilities and tabelecleucel trial results during May 2024-January 2026 period.
ATRAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··The Schall Law Firm

Atara Biotherapeutics Faces Securities Fraud Lawsuit Over Misleading Drug Trial Claims

Schall Law Firm launches class action against $ATRA for allegedly concealing manufacturing problems and overstating tabelecleucel prospects in ALLELE study.
ATRAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··The Schall Law Firm

Atara Biotherapeutics Faces Class Action Over Alleged Securities Fraud

Schall Law Firm recruits investors for class action against Atara Biotherapeutics over alleged securities fraud involving tabelecleucel drug and ALLELE study claims, covering May 2024-January 2026 purchases.
ATRAsecurities fraudclass action lawsuit
The Motley FoolThe Motley Fool··Rich Smith

ULA Grapples With Vulcan Rocket Reliability Issues as Leadership Transitions Loom

ULA's new Vulcan rocket faces reliability issues with two booster nozzle failures in four flights, compounded by leadership transition as CEO departs to Blue Origin.
BABApALMTNOCSpaceX competitionspace launch